$0.6312
-0.00880-1.38%
At close: -
$0.6220
-0.00920-1.46%
After Hours: 9:26 AM EDT
Comments
Loading...
Channel Therapeutics (AMEX:CHRO) Stock, Earnings Estimates, EPS, And Revenue
Channel Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 20
EPS Estimate
$-0.210
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Channel Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Channel Therapeutics (CHRO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-13 | $-0.29 | $-0.55 | 47.3 % |
Channel Therapeutics (CHRO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Channel Therapeutics (AMEX:CHRO) reporting earnings?
Channel Therapeutics (CHRO) is scheduled to report earnings on February 20, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for Channel Therapeutics (AMEX:CHRO)?
The Actual EPS was $-0.29, which beat the estimate of $-0.55.
What were Channel Therapeutics’s (AMEX:CHRO) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.